Chiron Real Estate Inc. annual report, FY2015

Business context and reporting period

Registrant discrepancy: The request identifies Chiron Real Estate Inc., but the supplied Form 10-K is for Global Medical REIT Inc. This summary reflects the filing provided. It covers the fiscal year ended December 31, 2015; the comparable 2014 period is only the four months from September 1 through December 31, following a fiscal-year change, so period comparisons are not directly meaningful.

Global Medical REIT acquires and leases purpose-built healthcare properties, generally under long-term triple-net leases. At year-end it owned four facilities. It is externally managed by an affiliate of its majority stockholder and reported no employees.

Financial results and position

At December 31, 2015, total assets were $65.329 million, including $55.149 million of net real estate and $9.184 million of cash. Restricted cash was $447,627. Total liabilities were $65.467 million and stockholders’ equity was negative $138,608. Liabilities included $40.030 million of convertible debentures due to the majority stockholder, $23.485 million of bank notes net of debt discount, and $421,000 of other notes payable to the majority stockholder. Interest expense was $1.519 million. The filing does not provide a clearly stated operating-margin metric.

Year-end rental revenue was concentrated: Omaha generated approximately 80%, with West Mifflin and Asheville about 10% each. Contractual minimum lease cash receipts in effect at year-end totaled $43.989 million over the remaining lease terms; these are future contractual amounts, not reported revenue or a guarantee of collection.

Material changes versus the prior period

• The portfolio grew from two properties at December 31, 2014 to four at December 31, 2015, following acquisitions in West Mifflin and Tennessee/Mississippi. The Tennessee acquisition closed on the final day of 2015 and generated no 2015 revenue.
• Real estate investment, net, increased to $55.149 million from $24.044 million; cash rose to $9.184 million from $88,806. These movements reflect acquisitions and financing, not comparable operating growth.
• Convertible debentures owed to the majority stockholder increased from $5.446 million to $40.030 million. Net bank notes increased from $16.468 million to $23.485 million.
• The net loss grew in dollar terms, but the reporting periods differ substantially in length, so the figures should not be read as a like-for-like deterioration.

Outlook, risks and unusual items

• Management said cash on hand, operating cash flow, financial-institution funding, and majority-stockholder funding were expected to meet liquidity needs for at least the next 12 months. This depends partly on continued access to related-party and external financing; the company also warned that real estate assets are illiquid.
• The company planned to elect REIT tax treatment beginning in 2016, subject to meeting qualification and distribution requirements. Failure to qualify could result in corporate-level taxes and affect future REIT eligibility.
• Subsequent to year-end, the company closed a $17.5 million Plano facility acquisition, financed in part with a $9.224 million bank loan and related-party debenture funding. It also reported proposed Melbourne and Westland acquisitions, which were not completed as of the filing date; the Westland transaction remained subject to due diligence and closing.
• On March 2, 2016, the majority stockholder converted $15 million of debenture principal into 1,176,656 common shares. The filing reports 1,426,656 shares outstanding as of March 21, while its beneficial-ownership disclosure uses 3,390,112 shares including shares issuable under conversion rights; investors should reconcile these figures.
• The company paid $255,600 in 2015 dividends despite a $1.609 million net loss and negative operating cash flow. The board controls future dividends, which depend on available funds and legal and REIT requirements.
• Key risks include tenant and healthcare-operator credit and reimbursement exposure, lease renewal and vacancy risk, interest rates and debt service, acquisition execution, and REIT compliance. The stock traded on the OTC Pink market with limited and sporadic trading and no assurance of liquidity.
• Related-party financing, management fees, and acquisition fees are material: the advisor’s $360,000 management fees for 2015 remained unpaid at year-end, and $627,000 of acquisition fees were expensed. The majority stockholder owned 99.5% of the shares at year-end. The board had no committees, and the independent auditor did not audit internal control over financial reporting.
• The auditor gave an unqualified opinion on the financial statements. Management concluded disclosure controls and internal control over financial reporting were effective at December 31, 2015; a prior-year filing-timing material weakness was described as isolated to 2014.

Most important facts for investors to verify

1. Confirm the correct registrant: the supplied filing is for Global Medical REIT Inc., not Chiron Real Estate Inc.
2. Reconcile the reported March 21, 2016 outstanding share count with the beneficial-ownership table and the debenture conversion, and assess resulting dilution and control.
3. Review the terms, maturity schedules, interest rates, and repayment capacity for bank debt and the large, demand-related-party debenture balance.
4. Assess whether operating cash flow and tenant collections can support expenses, debt service, planned acquisitions, and dividends without continued external funding.
5. Verify the status and final financing and lease terms of subsequent acquisitions, and the company’s ability to satisfy REIT requirements in 2016.